CLINICAL_TRIALS
trial_result
· 2017-12-28
Clinical Trial Update: Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension [Phase 4]
Summary
Phase 4 randomized trial comparing telmisartan to valsartan in adults with stage 1–2 hypertension; eight-week, double-blind, placebo-controlled forced-titration…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 4 | Status: COMPLETED